Shares of WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) were down 0.1% during mid-day trading on Friday . The company traded as low as $14.82 and last traded at $14.85. Approximately 502 shares were traded during mid-day trading, The stock had previously closed at $14.87.
WisdomTree BioRevolution Fund Stock Down 2.5 %
The stock has a market cap of $2.17 million, a PE ratio of 16.21 and a beta of 1.20. The firm has a fifty day moving average of $15.33 and a 200 day moving average of $15.98.
Institutional Investors Weigh In On WisdomTree BioRevolution Fund
A hedge fund recently bought a new stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC bought a new position in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,134 shares of the company’s stock, valued at approximately $217,000. Jane Street Group LLC owned about 8.76% of WisdomTree BioRevolution Fund at the end of the most recent quarter.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
See Also
- Five stocks we like better than WisdomTree BioRevolution Fund
- How to buy stock: A step-by-step guide for beginners
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 3 Small Caps With Big Return Potential
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.